A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC

PHASE3CompletedINTERVENTIONAL
Enrollment

281

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Small-Cell-Lung Cancer
Interventions
DRUG

Etoposide and cisplatin after chemoradiotherapy

Etoposide and cisplatin after chemoradiotherapy

DRUG

Irinotecan and cisplatin after chemoradiotherapy

Irinotecan and cisplatin after chemoradiotherapy

Trial Locations (37)

464-8681

Aichi Cancer Center Hospital, Nagoya,Chikusa-ku,Kanokoden,1-1

444-0011

Aichi Cancer Center,Aichi Hospital, Okazaki,Kake-machi,Kuriyado,18

277-8577

National Cancer Center Hospital East, Kashiwa-shi,Kashiwanoha,6-5-1

790-0007

National Hospital Organization Shikoku Cancer Center, Matsuyama,Horinouchi,13

812-8582

Kyushu University Hospital, Higashi-ku,Maidashi,3-1-1

500-8323

Gifu Municipal Hospital, Gifu,Kashima-cho,7-1

373-8550

Gunma Prefectural Cancer Center, Ota,Takabayashi-nishi-cho,617-1

377-8511

National Nishigunma Hospital, Shibukawa,Kanai,2854

070-8644

National Hospital Organization, Dohoku National Hospital, Asahikawa,Hanasaki,7-4048

003-0804

National Hospital Organization Hokkaido Cancer Center, Sapporo,Shiroishi-ku,Kikusui,4-2-3-54

673-8558

Hyogo Medical Center for Adults, Akashi,Kitaouji-cho,13-70

650-0046

Kobe City General Hospital, Kobe,Chuo-ku,Minatojimanakamachi,4-6

663-8501

Hyogo College of Medicine, Nishinomiya,Mukogawa-cho,1-1

309-1793

Ibaraki Kenritsu Chuo Hospital & Cancer Center, Nishi-ibarakigun,Tomobemachi,Koibuchi,6528

241-0815

Kanagawa Cancer Center, Yokohama,Asahi-ku,Nakao,1-1-2

240-8555

Yokohama Mucipical Citizen's Hospital, Yokohama,Hodogaya-ku,Okazawa-cho,56

860-0811

Kumamoto Regional Medical Center Hospital, Kumamoto,Honjo,5-16-10

980-0874

Tohoku University Hospital, Sendai,Aoba-ku,Seiryo-machi,1-1

951-8566

Niigata Cancer Center Hospital, Niigata,Kawagishi-cho,2-15-3

700-8558

Okayama University Hospital, Okayama,Shikata-cho,2-5-1

583-8588

Osaka Prefectural Medical Center for Respiratory and Allergic Disease, Habikino,Habikino,3-7-1

598-0048

Rinku General Medical Center, Izumisano,rinku-ohrai-kita,2-23

545-0051

Graduate School of Medicine, Osaka City University, Osaka,Abeno-ku,Asahi-machi,1-5-7

537-8511

Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka,Higashinari-ku,Nakamichi,1-3-3

534-0021

Osaka City General Hospital, Osaka,Miyakojima-ku,Miyakojimahondori,2-13-22

558-8558

Osaka General Medical Center, Osaka,Sumiyoshi-ku,Bandai-higashi,3-1-56

589-8511

Kinki University School of Medicine, Osaka-Sayama,Ohno-higashi,377-2

591-8555

National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai,Nagasone,1180

560-8552

National Hospital Organization Toneyama National Hospital, Toyonaka,Toneyama,5-1-1

362-0806

Saitama Cancer Center, Kita-adachi,Ina,Komuro,818

411-8777

Sizuoka Cancer Center, Sunto-gun,Nagaizumi-cho,Shimonagakubo,1007

320-0834

Tochigi Cancer Center, Utsunomiya,Yohnan,4-9-13

104-0045

National Cancer Center Hospital, Chuo-ku,Tsukiji,5-1-1

135-8550

Cancer Institute Hospital, Koto-ku,Ariake,3-10-6

105-8470

Toranomon Hospital, Minato-ku,Toranomon,2-2-2

162-8655

International Medical Center of Japan, Shinjuku-ku,Toyama,1-21-1

990-2292

Yamagata Prefectural Central Hospital, Yamagata,Aoyagi,1800

All Listed Sponsors
collaborator

Ministry of Health, Labour and Welfare, Japan

OTHER_GOV

lead

Haruhiko Fukuda

OTHER

NCT00144989 - A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | Biotech Hunter | Biotech Hunter